129 related articles for article (PubMed ID: 15910938)
1. Nod2 and Crohn's disease: many connected highways.
Meinzer U; Hugot JP
Lancet; 2005 May 21-27; 365(9473):1752-4. PubMed ID: 15910938
[No Abstract] [Full Text] [Related]
2. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.
Netea MG; Ferwerda G; de Jong DJ; Jansen T; Jacobs L; Kramer M; Naber TH; Drenth JP; Girardin SE; Kullberg BJ; Adema GJ; Van der Meer JW
J Immunol; 2005 May; 174(10):6518-23. PubMed ID: 15879155
[TBL] [Abstract][Full Text] [Related]
4. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
5. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
6. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.
Kobayashi KS; Chamaillard M; Ogura Y; Henegariu O; Inohara N; Nuñez G; Flavell RA
Science; 2005 Feb; 307(5710):731-4. PubMed ID: 15692051
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory diseases: is ubiquitinated NEMO at the hub?
Burns KA; Martinon F
Curr Biol; 2004 Dec; 14(24):R1040-2. PubMed ID: 15620634
[TBL] [Abstract][Full Text] [Related]
8. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
[TBL] [Abstract][Full Text] [Related]
9. Impaired innate immunity in Crohn's disease.
Comalada M; Peppelenbosch MP
Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility and regulation of inflammation in Crohn's disease. Relationship with the innate immune system.
Peña AS; Peñate M
Rev Esp Enferm Dig; 2002 Jun; 94(6):351-60. PubMed ID: 12432592
[No Abstract] [Full Text] [Related]
11. How NOD-ing off leads to Crohn disease.
O'Neill LA
Nat Immunol; 2004 Aug; 5(8):776-8. PubMed ID: 15282558
[No Abstract] [Full Text] [Related]
12. How NOD2 and autophagy may be related to Crohn's disease? A view shifted from live microbes to luminal bacterial debris.
Qin X
J Crohns Colitis; 2014 Jan; 8(1):88. PubMed ID: 23969121
[No Abstract] [Full Text] [Related]
13. CARD 15 and toll-like receptors: the link with Crohn's disease.
Caprilli R; Guagnozzi D
Dig Liver Dis; 2003 Nov; 35(11):753-7. PubMed ID: 14674662
[No Abstract] [Full Text] [Related]
14. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
15. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.
Watanabe T; Kitani A; Strober W
Gut; 2005 Nov; 54(11):1515-8. PubMed ID: 16227353
[No Abstract] [Full Text] [Related]
16. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.
Watanabe T; Kitani A; Murray PJ; Strober W
Nat Immunol; 2004 Aug; 5(8):800-8. PubMed ID: 15220916
[TBL] [Abstract][Full Text] [Related]
17. NOD proteins: an intracellular pathogen-recognition system or signal transduction modifiers?
Murray PJ
Curr Opin Immunol; 2005 Aug; 17(4):352-8. PubMed ID: 15950446
[TBL] [Abstract][Full Text] [Related]
18. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
Netea MG; Ferwerda G; de Jong DJ; Girardin SE; Kullberg BJ; van der Meer JW
Neth J Med; 2005 Sep; 63(8):305-8. PubMed ID: 16186640
[TBL] [Abstract][Full Text] [Related]
19. [Chemical structures of bacterial peptidoglycan and immunomodulation in mammals].
Takada H; Uehara A
Tanpakushitsu Kakusan Koso; 2004 Jun; 49(8):1161-7. PubMed ID: 15209210
[No Abstract] [Full Text] [Related]
20. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
